These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17189288)

  • 21. Association of IRF5 polymorphisms with activation of the interferon alpha pathway.
    Rullo OJ; Woo JM; Wu H; Hoftman AD; Maranian P; Brahn BA; McCurdy D; Cantor RM; Tsao BP
    Ann Rheum Dis; 2010 Mar; 69(3):611-7. PubMed ID: 19854706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5.
    Sigurdsson S; Nordmark G; Garnier S; Grundberg E; Kwan T; Nilsson O; Eloranta ML; Gunnarsson I; Svenungsson E; Sturfelt G; Bengtsson AA; Jönsen A; Truedsson L; Rantapää-Dahlqvist S; Eriksson C; Alm G; Göring HH; Pastinen T; Syvänen AC; Rönnblom L
    Hum Mol Genet; 2008 Sep; 17(18):2868-76. PubMed ID: 18579578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of a common interferon regulatory factor 5 (IRF5) variant with increased risk of systemic lupus erythematosus (SLE).
    Demirci FY; Manzi S; Ramsey-Goldman R; Minster RL; Kenney M; Shaw PS; Dunlop-Thomas CM; Kao AH; Rhew E; Bontempo F; Kammerer C; Kamboh MI
    Ann Hum Genet; 2007 May; 71(Pt 3):308-11. PubMed ID: 17166181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promoter insertion/deletion in the IRF5 gene is highly associated with susceptibility to systemic lupus erythematosus in distinct populations, but exerts a modest effect on gene expression in peripheral blood mononuclear cells.
    Löfgren SE; Yin H; Delgado-Vega AM; Sanchez E; Lewén S; Pons-Estel BA; Witte T; D'Alfonso S; Ortego-Centeno N; Martin J; Alarcón-Riquelme ME; Kozyrev SV
    J Rheumatol; 2010 Mar; 37(3):574-8. PubMed ID: 20080916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA-Seq for enrichment and analysis of IRF5 transcript expression in SLE.
    Stone RC; Du P; Feng D; Dhawan K; Rönnblom L; Eloranta ML; Donnelly R; Barnes BJ
    PLoS One; 2013; 8(1):e54487. PubMed ID: 23349905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opposed independent effects and epistasis in the complex association of IRF5 to SLE.
    Ferreiro-Neira I; Calaza M; Alonso-Perez E; Marchini M; Scorza R; Sebastiani GD; Blanco FJ; Rego I; Pullmann R; Pullmann R; Kallenberg CG; Bijl M; Skopouli FN; Mavromati M; Migliaresi S; Barizzone N; Ruzickova S; Dostal C; Schmidt RE; Witte T; Papasteriades C; Kappou-Rigatou I; Endreffy E; Kovacs A; Ordi-Ros J; Balada E; Carreira P; Gomez-Reino JJ; Gonzalez A
    Genes Immun; 2007 Jul; 8(5):429-38. PubMed ID: 17568788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans.
    Kelly JA; Kelley JM; Kaufman KM; Kilpatrick J; Bruner GR; Merrill JT; James JA; Frank SG; Reams E; Brown EE; Gibson AW; Marion MC; Langefeld CD; Li QZ; Karp DR; Wakeland EK; Petri M; Ramsey-Goldman R; Reveille JD; Vilá LM; Alarcón GS; Kimberly RP; Harley JB; Edberg JC
    Genes Immun; 2008 Apr; 9(3):187-94. PubMed ID: 18288123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus.
    Niewold TB; Kelly JA; Kariuki SN; Franek BS; Kumar AA; Kaufman KM; Thomas K; Walker D; Kamp S; Frost JM; Wong AK; Merrill JT; Alarcón-Riquelme ME; Tikly M; Ramsey-Goldman R; Reveille JD; Petri MA; Edberg JC; Kimberly RP; Alarcón GS; Kamen DL; Gilkeson GS; Vyse TJ; James JA; Gaffney PM; Moser KL; Crow MK; Harley JB
    Ann Rheum Dis; 2012 Mar; 71(3):463-8. PubMed ID: 22088620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of IRF5 gene functional polymorphisms in rheumatoid arthritis.
    Rueda B; Reddy MV; González-Gay MA; Balsa A; Pascual-Salcedo D; Petersson IF; Eimon A; Paira S; Scherbarth HR; Pons-Estel BA; González-Escribano MF; Alarcón-Riquelme ME; Martín J
    Arthritis Rheum; 2006 Dec; 54(12):3815-9. PubMed ID: 17133578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis.
    Dieguez-Gonzalez R; Calaza M; Perez-Pampin E; de la Serna AR; Fernandez-Gutierrez B; Castañeda S; Largo R; Joven B; Narvaez J; Navarro F; Marenco JL; Vicario JL; Blanco FJ; Fernandez-Lopez JC; Caliz R; Collado-Escobar MD; Carreño L; Lopez-Longo J; Cañete JD; Gomez-Reino JJ; Gonzalez A
    Arthritis Rheum; 2008 May; 58(5):1264-74. PubMed ID: 18438842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between the interferon regulatory factor 5 rs2004640 functional polymorphism and systemic lupus erythematosus: an updated meta-analysis.
    Bae SC; Lee YH
    Lupus; 2019 May; 28(6):740-747. PubMed ID: 31018759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon regulatory factor 5 gene polymorphism confers risk to several rheumatic diseases and correlates with expression of alternative thymic transcripts.
    Nordang GB; Viken MK; Amundsen SS; Sanchez ES; Flatø B; Førre OT; Martin J; Kvien TK; Lie BA
    Rheumatology (Oxford); 2012 Apr; 51(4):619-26. PubMed ID: 22179739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of polymorphisms across the tyrosine kinase gene, TYK2 in UK SLE families.
    Cunninghame Graham DS; Akil M; Vyse TJ
    Rheumatology (Oxford); 2007 Jun; 46(6):927-30. PubMed ID: 17384181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity.
    Dieude P; Dawidowicz K; Guedj M; Legrain Y; Wipff J; Hachulla E; Diot E; Sibilia J; Mouthon L; Cabane J; Amoura Z; Crakowski JL; Carpentier P; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
    J Rheumatol; 2010 May; 37(5):987-92. PubMed ID: 20231204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between IRF5 polymorphisms and autoimmune diseases: a meta-analysis.
    Tang L; Chen B; Ma B; Nie S
    Genet Mol Res; 2014 Jun; 13(2):4473-85. PubMed ID: 25036352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IRF5 genetic risk variants drive myeloid-specific IRF5 hyperactivation and presymptomatic SLE.
    Li D; Matta B; Song S; Nelson V; Diggins K; Simpfendorfer KR; Gregersen PK; Linsley P; Barnes BJ
    JCI Insight; 2020 Jan; 5(2):. PubMed ID: 31877114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene-gene interactions of IRF5, STAT4, IKZF1 and ETS1 in systemic lupus erythematosus.
    Dang J; Shan S; Li J; Zhao H; Xin Q; Liu Y; Bian X; Liu Q
    Tissue Antigens; 2014 Jun; 83(6):401-8. PubMed ID: 24697319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share.
    Kottyan LC; Zoller EE; Bene J; Lu X; Kelly JA; Rupert AM; Lessard CJ; Vaughn SE; Marion M; Weirauch MT; Namjou B; Adler A; Rasmussen A; Glenn S; Montgomery CG; Hirschfield GM; Xie G; Coltescu C; Amos C; Li H; Ice JA; Nath SK; Mariette X; Bowman S; ; Rischmueller M; Lester S; Brun JG; Gøransson LG; Harboe E; Omdal R; Cunninghame-Graham DS; Vyse T; Miceli-Richard C; Brennan MT; Lessard JA; Wahren-Herlenius M; Kvarnström M; Illei GG; Witte T; Jonsson R; Eriksson P; Nordmark G; Ng WF; ; Anaya JM; Rhodus NL; Segal BM; Merrill JT; James JA; Guthridge JM; Scofield RH; Alarcon-Riquelme M; Bae SC; Boackle SA; Criswell LA; Gilkeson G; Kamen DL; Jacob CO; Kimberly R; Brown E; Edberg J; Alarcón GS; Reveille JD; Vilá LM; Petri M; Ramsey-Goldman R; Freedman BI; Niewold T; Stevens AM; Tsao BP; Ying J; Mayes MD; Gorlova OY; Wakeland W; Radstake T; Martin E; Martin J; Siminovitch K; Moser Sivils KL; Gaffney PM; Langefeld CD; Harley JB; Kaufman KM
    Hum Mol Genet; 2015 Jan; 24(2):582-96. PubMed ID: 25205108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relationship between polymorphism sites of IRF5, TLR-9 and SLE patients in Shandong Han population].
    Song WQ; Li HH; Chen HB; Yuan JS; Yin XJ
    Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(43):3038-42. PubMed ID: 20137629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exon 6 variants carried on systemic lupus erythematosus (SLE) risk haplotypes modulate IRF5 function.
    Wen F; Ellingson SM; Kyogoku C; Peterson EJ; Gaffney PM
    Autoimmunity; 2011 Mar; 44(2):82-9. PubMed ID: 20695768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.